Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/214370
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | El Haj, Cristina | - |
dc.contributor.author | Agustí, Eugènia | - |
dc.contributor.author | Benavent, Eva | - |
dc.contributor.author | Soldevila-boixader, Laura | - |
dc.contributor.author | Rigo-bonnin, Raül | - |
dc.contributor.author | Tubau, Fe | - |
dc.contributor.author | Torrejón, Benjamín | - |
dc.contributor.author | Esteban, Jaime | - |
dc.contributor.author | Murillo, Oscar | - |
dc.date.accessioned | 2024-07-05T11:54:46Z | - |
dc.date.available | 2024-07-05T11:54:46Z | - |
dc.date.issued | 2024-04-09 | - |
dc.identifier.uri | http://hdl.handle.net/2445/214370 | - |
dc.description.abstract | Background: As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against Pseudomonas aeruginosa biofilm. Methods: We have used the Center for Disease Control and Prevention Biofilm Reactor with two susceptible (PAO1 and HUB-PAS) and one resistant (HUB-XDR) strains of P. aeruginosa. The regimens were CAZ monotherapies (mimicking a human dose of 2 g/8 h, CAZ-IB; 6 g/daily as continuous infusion at 50 mg/L, CAZ-CI50; and 9 g/daily at 70 mg/L, CAZ-CI70) and CAZ-colistin combinations. Efficacy was correlated with the CAZ PK/PD parameters. Results: CAZ-CI70 was the most effective monotherapy against CAZ-susceptible strains (Delta log CFU/mL 54-0 h = -4.15 +/- 0.59 and -3.05 +/- 0.5 for HUB-PAS and PAO1, respectively; p <= 0.007 vs. other monotherapies), and adding colistin improved the efficacy over CAZ monotherapy. CAZ monotherapies were ineffective against the HUB-XDR strain, and CAZ-CI50 plus colistin achieved higher efficacy than CAZ-IB with colistin. The PK/PD index that correlated best with anti-biofilm efficacy was fAUC(0-24h)/MIC (r(2) = 0.78). Conclusions: CAZ exhibited dose-dependent anti-biofilm killing against P. aeruginosa, which was better explained by the fAUC(0-24h)/MIC index. CAZ-CI provided benefits compared to CAZ-IB, particularly when using higher doses and together with colistin. CAZ monotherapies were ineffective against the CAZ-resistant strain, independently of the optimized strategy and only CAZ-CI plus colistin appeared useful for clinical practice. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI AG | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/antibiotics13040344 | - |
dc.relation.ispartof | Antibiotics, 2024, vol. 13, issue. 4, p. 344 | - |
dc.relation.uri | https://doi.org/10.3390/antibiotics13040344 | - |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.title | Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Pseudomonas aeruginosa Biofilm | - |
dc.type | info:eu-repo/semantics/article | - |
dc.date.updated | 2024-06-20T14:41:03Z | - |
dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
antibiotics-13-00344.pdf | 679.99 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.